CRISPR screens identify ZBTB7A as a tumor suppressor gene, and therapeutic targeting of KDM4 restores its expression to promote AML differentiation.

Abstract. Aberrant levels or structures of RNA isoforms are a hallmark of many cancers, including acute myeloid leukemia (AML), yet its role in AML chemoresistance remains unclear. We conducted a pair...